# OnCo record telesto (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/telesto/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "telesto", "NCT00940602" ;
  schema:name "TELESTO"@en ;
  schema:alternateName "CICL670A2302"@en ;
  schema:description "TELESTO is the only placebo-controlled trial of removing excess iron in people with lower-risk myelodysplastic syndrome who depend on blood transfusions; the chelator deferasirox lengthened the time before heart or liver damage, progression to leukaemia or death by about a year."@en ;
  schema:url <https://onco.cc/trials/telesto/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00940602>, <https://clinicaltrials.gov/study/NCT00940602?tab=results> ;
  onco:status "positive" ;
  onco:tag "soc-trials" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/mds-lower-risk/>, <https://onco.cc/cancers/mds/> ;
  onco:companies <https://onco.cc/companies/novartis/> .